Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Mathijssen, Ron H J"'
Autor:
Rietveld PCS; Department of Clinical Pharmacy, Erasmus MC, Rotterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands., Sassen SDT; Department of Clinical Pharmacy, Erasmus MC, Rotterdam, The Netherlands.; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands., Guchelaar NAD; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Eerden RAG; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Boer NL; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van den Heuvel TBM; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Burger JWA; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Koch BCP; Department of Clinical Pharmacy, Erasmus MC, Rotterdam, The Netherlands.; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands., Koolen SLW; Department of Clinical Pharmacy, Erasmus MC, Rotterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Jun; Vol. 13 (6), pp. 1006-1016. Date of Electronic Publication: 2024 Apr 17.
Autor:
Karas S; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Etheridge AS; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Nickerson DA; Department of Genome Sciences, University of Washington, Seattle, WA, USA., Cox NJ; Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA., Mohlke KL; Department of Genetics, University of North Carolina, Chapel Hill, NC, USA., Cecchin E; Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Toffoli G; Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Forrest A; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Bies RR; Department of Pharmaceutical Sciences, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.; Computational and Data Enabled Sciences and Engineering Program, University at Buffalo, State University of New York at Buffalo, Buffalo, NY, USA., Innocenti F; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. innocent@email.unc.edu.
Publikováno v:
British journal of cancer [Br J Cancer] 2022 Mar; Vol. 126 (4), pp. 640-651. Date of Electronic Publication: 2021 Oct 26.
Autor:
de Man FM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Eerden RAG; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Doorn GM; Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Olieman JF; Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Veraart JN; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Halteren HK; Department of Internal Medicine, Admiraal de Ruyter Hospital, Goes, The Netherlands., Sandberg Y; Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands., Moelker A; Department of Radiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., IJzermans JNM; Department of Surgery, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Gelder T; Department of Hospital Pharmacy, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Dollé MET; Centre for Health Protection Research, National Institute for Public Health and Environment (RIVM), Bilthoven, The Netherlands., de Bruin RWF; Department of Surgery, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 May; Vol. 109 (5), pp. 1304-1313. Date of Electronic Publication: 2020 Dec 06.
Autor:
Karas S; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Etheridge AS; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Tsakalozou E; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Ramírez J; Department of Medicine, University of Chicago, Chicago, IL, USA., Cecchin E; Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., van Schaik RHN; Department of Clinical Chemistry, Erasmus MC, Rotterdam, Netherlands., Toffoli G; Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Ratain MJ; Department of Medicine, University of Chicago, Chicago, IL, USA., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Forrest A; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Bies RR; Department of Pharmaceutical Sciences, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY, USA. robertbi@buffalo.edu.; Computational and Data Enabled Sciences and Engineering Program, University at Buffalo, State University of New York at Buffalo, Buffalo, NY, USA. robertbi@buffalo.edu., Innocenti F; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. innocent@email.unc.edu.
Publikováno v:
The AAPS journal [AAPS J] 2020 Mar 17; Vol. 22 (3), pp. 59. Date of Electronic Publication: 2020 Mar 17.
Autor:
de Boer NL; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Brandt-Kerkhof ARM; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Madsen EVE; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Diepeveen M; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Meerten E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Eerden RAG; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Man FM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Bouamar R; Department of Hospital Pharmacy, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands., de Hingh IHJT; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands., Bakkers C; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands., Rovers KP; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands., Creemers GM; Department of Medical Oncology, Catharina Cancer Institute, Eindhoven, The Netherlands., Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands., Kranenburg OW; Department of Surgical Oncology and Utrecht Platform for Organoid Technology, UMC Utrecht Cancer Centre, Utrecht, The Netherlands., Constantinides A; Department of Surgical Oncology and Utrecht Platform for Organoid Technology, UMC Utrecht Cancer Centre, Utrecht, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Verhoef C; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Burger JWA; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands pim.burger@catharinaziekenhuis.nl.; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands.
Publikováno v:
BMJ open [BMJ Open] 2019 Dec 08; Vol. 9 (12), pp. e034508. Date of Electronic Publication: 2019 Dec 08.
Autor:
de Man FM; Department of Medical Oncology, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, 3015, Rotterdam, The Netherlands., Goey AKL; Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, 3015, Rotterdam, The Netherlands., Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, 's-Gravendijkwal 230, 3015, Rotterdam, The Netherlands. s.bins@erasmusmc.nl.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2018 Oct; Vol. 57 (10), pp. 1229-1254.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Guchelaar, Niels A. D., Buck, Stefan A. J., van Doorn, Leni, Hussaarts, Koen G. A. M., Sandberg, Yorick, van der Padt-Pruijsten, Annemieke, van Alphen, Robbert J., Poppe-Manenschijn, Laura, Vleut, Isolde, de Bruijn, Peter, van Leeuwen, Roelof W. F., Mostert, Bianca, Eskens, Ferry A. L. M., Oomen-de Hoop, Esther, Koolen, Stijn L. W., Mathijssen, Ron H. J.
Publikováno v:
Clinical Pharmacokinetics; Jul2024, Vol. 63 Issue 7, p1037-1044, 8p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.